Scott Seeley
Eastgate IP
Scott is an intellectual property lawyer and registered patent attorney.
Scott was trained at one of the nation’s top intellectual property law firms. Prior to Eastgate IP, Scott practiced intellectual property law as a patent attorney at Knobbe Martens, managing portfolios of intellectual property, prosecuting patent applications, and conducting due diligence for companies of all sizes – including Fortune 500 companies, start-ups, and independent inventors.
Scott has prosecuted patents across a wide range of technologies including software, mechanical devices, medical devices, cosmetics, food & beverage, and biotechnology. Scott has extensive experience preparing infringement opinions and conducting validity analyses of competitor portfolios.
Scott’s technical expertise and knowledge of intellectual property law helps clients achieve allowance and protect the value in their intellectual property.
- Intellectual Property
- Patents
- Patent Appeals, Patent Litigation, Patent Prosecution
- Trademarks
- Trademark Litigation, Trademark Registration
- Arbitration & Mediation
- Business - Arbitration/Mediation, Consumer - Arbitration/Mediation, Family - Arbitration/Mediation
- Free Consultation
- Credit Cards Accepted
- United States Patent and Trademark Office
- ID Number: 76800
- Washington
- Washington State Bar Association
- ID Number: 50272
- English: Spoken, Written
- Co-Founder, Registered Patent Attorney
- Eastgate IP
- - Current
- Registered Patent Attorney
- Knobbe Martens
- -
- Summer Associate
- Knobbe Martens
- -
- Judicial Extern
- United States District Court, Eastern District WA
- -
- University of Washington School of Law
- J.D. (2015) | Law
- -
- Central Washington University
- B.S. (2012) | Chemistry, Biochemistry Specialization
- -
- Honors: cum laude
- Rising Star
- Super Lawyers
- Legal Falcon
- LexTalk World
- Patent Trial and Appeal Board Bar Association
- Current
- American Intellectual Property Law Association
- Current
- Intellectual Property Issues Under The Trans-Pacific Partnership
- Biosimilar Development